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Abstract
Understanding the different effects of chemical substances on human proteins is fundamental for designing new
drugs. It is also important for elucidating the different mechanisms of action of drugs that can cause side-effects. In
this context, computational methods for predicting chemical–protein interactions can provide valuable insights on the
relation between therapeutic chemical substances and proteins. Their predictions therefore can help in multiple tasks
such as drug repurposing, identifying new drug side-effects, etc. Despite their useful predictions, these methods are
unable to predict the different implications —such as change in protein expression, abundance, etc,— of chemical–
protein interactions. Therefore, In this work, we study the modelling of chemical–protein interactions’ effects on
proteins activity using computational approaches. We hereby propose using 3D tensors to model chemicals, their
target proteins and the effects associated to their interactions. We then use multi-part embedding tensor factorisation to
predict the different effects of chemicals on human proteins. We assess the predictive accuracy of our proposed method
using a benchmark dataset that we built. We then show by computational experimental evaluation that our approach
outperforms other tensor factorisation methods in the task of predicting effects of chemicals on human proteins.
Introduction
Understanding the different effects of chemical substances on human proteins is fundamental for designing new drugs.
It is also important for elucidating the different mechanisms-of-action of current drugs that can cause unwanted side-
effects (1). This encouraged researchers to investigate the different chemical–protein interactions and their effects on the
protein activity in living systems. Chemicals can have different types of effects on their target proteins such as change
of expression, abundance, secretion, etc. These different effects then play various roles in the mechanism-of-action of
chemicals in living systems. Therefore, understanding the chemical–protein interactions with their respective effects is
crucial to elucidating the mechanism-of-action of therapeutic chemical substances.
The process of investigating chemical–protein interactions and their effects commonly involves ‘omics approaches
such as mass spectrometry which is used for the generation of proteomic data. This method is mainly used to identify
off-target or non-canonical targets of chemicals (drugs) that may be unknown (2, 3). Other lab approaches include
phenotypic screening such as work carried out by Iljin et. al. (4) whereby 4910 drug-like small molecule compounds
were tested against prostate cancer cell lines to identify which ones affected cell proliferation (4). Despite the insightful
findings of such approaches, they are laborious, time-consuming and resource-consuming processes.
This encouraged the development of different computational approaches to inform and assist laboratory experimentation
of chemical–protein interactions (5–7). These approaches enabled predicting the most plausible chemical–protein
interactions with high accuracy and efficiency (6, 7). However, all the current computational approaches are only focused
on predicting the existence of chemical–protein interactions, and they do not provide any information on the effects of
these interactions.
In this study, we extend the design of traditional chemical–protein interaction computational approach to allow them
to encode the different types of effects caused by these interaction on target proteins. We model the information on
chemicals, their target proteins and associated interaction effects as 3D where we can easily apply tensor factorisation
methods to infer new unknown chemical–protein interactions’ effects.
Tensor factorisation methods have been widely adopted in different biological tasks including drug–target interaction
prediction (7, 8), drug side-effect prediction (9, 10), protein biological functions prediction (11), etc. Tensor factorisation
approaches were then used to generate vector representations of biological entities to provide predictions of their
unknown associations to other entities.
In the context of our study, we use tensor factorisation methods to generate embeddings of chemicals, their targeted
proteins and corresponding chemical effects. We then use these embeddings to predict new possible chemical–protein
interactions and their associated chemical effects. We use a multi-part tensor factorisation approach that models tensor
objects’ embeddings using multiple tensors and we show that this approach has better accuracy than other tensor
factorisation approaches. To the best of our knowledge, this work is the first computational method that considers the
context of chemical effects in predicting chemical–protein interactions. Therefore, we only compare our method to
other tensor factorisation approaches.
We build a benchmarking dataset that consists of known chemical–protein interactions with their associated chemical
effects extracted from the Comparative Toxicogenomics Database (CTD) (12, 13). We then show by computational
experimental evaluation on this benchmark that our proposed multi-part tensor factorisation approach outperforms all
other approaches in the task of predicting chemical–protein interactions and their associated chemical effects.
The rest of this study is outlined as follows: the background section presents a brief background on the studied problem
and proposed approach. The materials section discusses the benchmarking dataset used in this study. The methods
section discusses the design details of our approach. The results section presents the experimental setup of our evaluation
benchmark and the outcome results. The discussion presents the findings of this study and discuss the challenges and
limitations of the proposed approach.
Background
In this section, we discuss the preliminary concepts and notations that we use through this study. We first discuss the
problem of the different systematic approaches used for drug repurposing. We then discuss the tensor factorisation
model and other notations that we use during the training and evaluation of our approach.
Drug repurposing approaches. Drug repurposing is the use and effectiveness of well-known drugs for alternative
diseases other than the disease it was originally designed for (14). This is a more cost-effective and time-efficient process
than developing new drugs, as it bypasses the need for the drug to go through Phase I of the clinical trials since it
already has a known safety profile (15). For this reason, more systematic approaches have been developed including
both computational and experimental approaches.
The first example of a computational approach includes signature matching-comparing transcriptomics, chemical
structures or adverse drug effects between two different drugs. Increased similarity in these signatures indicates similar
targets (16–18). Other examples include the use of genome-wide association studies (GWAS) whereby an association
of a genetic loci with one disease may also be associated with other diseases. This shared association may indicate
the potential to use the same drug to treat the diseases (19). Another approach involves retrospective analysis of
electronic health records which has been useful in alluding to the repurposing of drugs. This approach has been used
for repurposing drugs like Sildenafil Citrate (20). Furthermore, it was also recently used for repurposing Aspirin which
was originally used for cardiovascular diseases but has now been recommended by the US Preventive Services Task
Force for the chemoprevention of colorectal cancer (21).
In this work however, the scope of our study is focused on computational approaches that utilize information about the
drug–protein interactions and their chemical effects on the protein activity.
Tensor factorisation. Scalars are singular numerical values, vectors are one dimensional numerical arrays, matrices
are two dimensional numerical arrays, and tensors are numerical arrays with three or more dimensions. In our
study, we focus on tensors with only three dimensions. In this case, a tensor cell represents the interaction between
three components from the different tensor dimensions. This interaction commonly denotes the likelihood of a joint
association between the three components which are represented by the cell. In practice, each dimension of a tensor
data model represents components from a specific type such as chemicals or proteins in our case. For example, let us
assume that we have a 3D tensor of chemicals, effects and protein targets. The value of the cell corresponding to the
three components (1-nitropyrene, decreases_expression, LRRC17) will be 1 if the chemical "1-nitropyrene" has the
effect "decreases_expression" on the protein target "LRRC17" and 0 otherwise.
The objective of the procedure of tensor decomposition i.e. tensor factorisation, is to complete all cell values in
an incomplete tensor using a set of initial known cell values. This procedure is achieved by learning numerical
representations of different tensor objects. The representations (i.e. embeddings) are then used to provide scores for any
given tensor combination.
Let M be a three dimensional tensor, where the three dimensions represent objects of different sets X , Y , Z. Any
element (i, j, k) in the tensor represents the interaction between the components i ∈ X , j ∈ Y , and k ∈ Z. We
denote the weight of this interaction using ηM(i, j, k). In this study, we use a tensor M with elements of the three
sets: chemicals (C), effects (E), and target proteins (P). The objective of tensor decomposition then is to complete the
tensor values such that the weight of any interaction of a true known chemical effect on a protein target is larger than all
other known false combinations. This can be defined as follows:
∀(c, e, p)∀(c, e, p)′ ηM(c, e, p) > ηM(c, e, p)′ (1)
where c ∈ C, e ∈ E, p ∈ P, (c, e, p) is any known true combination of a chemical, an effect and a target protein such
that the chemical c has the effect e on the protein p, and combinations (c, e, p)′ represent any other false combinations.
This objective is achieved using a multi-phase procedure where the model iteratively learns the missing scores by
processing each of the initially known tensor combinations. In this work, we use the learning procedure of knowledge
graph embedding models (22). First, each object represented in the tensor is associated with initial random embeddings;
these embeddings are then updated during the learning process such that the interactions of embeddings (i.e. the scoring
function) yields high values for true combinations and lower values otherwise. Different models were developed to
perform tensor decomposition where they vary in their modelling of the object embeddings, embedding interaction
functions, and training objectives.
Ranking training objectives. Tensor factorisation models traditionally use learning-to-rank loss functions as their
training objectives. This allows them to perform tensor completion through ranking tensor combinations according to
their factuality. They use different approaches for modelling ranking objectives such as pairwise and pointwise loss
objectives. For example, the DistMult model uses a pointwise hinge loss function. Its objective is then to minimise the
marginal difference between negative and positive scores (23), therefore, this makes the scores of positive combinations
always higher than the scores of the negative combinations as shown in Eq. 1. On the other hand, other tensor
factorisation models such as the ComplEx model (24) uses a pointwise logistic objective which aims to minimise the
difference between combination scores and their assigned targets.
Materials
In this study, we use a drug target interaction dataset extracted from the Comparative Toxicogenomics Database
(CTD) (12, 13). The CTD database contains data on chemicals, pathways, diseases, exposures, genes and phenotypes. It
also contains different types of associations between these entities. In our study, we only consider the chemical gene
associations where we filter out the interactions according to the related species to keep only the interactions assigned
to humans.
We build a new benchmarking dataset, CTD38E, which contains associations between chemicals and their human
protein targets from the CTD data. It also includes the different effect types related to these associations between the
chemicals and proteins. The dataset includes a set of 38 different chemical effects which are filtered according to their
coverage where we only keep effects that have 500 instances or more. We further divide the dataset into training and
testing splits with 90% and 10% ratios respectively for the training and evaluation pipeline.
The different chemical effects describe an increase, decrease or uncategorised effect on the different protein attributes
and activities such as methylation, oxidation, etc. For example, a chemical effect on a protein can increase the protein
expression, decrease its abundance, have a general effect on its binding, etc.
The generated CTD38E dataset have a variable coverage of chemical effects where the change of protein expression
associated effects have the highest coverage. Also, 32 out of the 38 represented chemical effects have approximately
≈ 15k or less instances in the dataset. On the other hand, the remaining effects have variable coverage that varies from






















Figure 1: Summary of training and evaluation pipeline of the TriVec tensor factorisation approach. The abbreviation
CPE denotes chemical protein effect.
Methods
In this work, we use the TriVec tensor factorisation approach which provides an efficient means for modelling 3D
tensors using multi-part embeddings. It also uses a multi-component embedding interaction function and multi-class
training objective. In the following, we discuss the design of the TriVec tensor factorisation method and its training and
evaluation pipelines. We further discuss its different unique properties such as its scoring function, training objective
and embedding representation.
The training and prediction pipelines. The tensor factorisation process operates by learning vector representations for
the different tensor objects during the training phase. These representations are then used to predict the probability
of unknown tensor combinations. (Figure 1) presents an illustration of the training and prediction pipelines of our
approach, the TriModel.
In the training phase, our approach starts with consuming the set of known tensor combinations and an initial set of
embeddings of the tensor objects as shown in (Figure 1). The method then iteratively processes the known tensor
combinations to update the initial embeddings. The updates to the embeddings vectors are executed through a batch-
based gradient decent optimisation procedure (25). The objective of this optimisation procedure is to maximise the
scores of the given true combinations and to minimise the scores of other random combinations as specified in (Eq. 1).
This objective is dependent on the methods scoring function, i.e. embedding interaction function, where this function
provides a score for each tensor combination using the embeddings of its objects.
The consumed known combinations, in this context, represent the training split of the CTD38E dataset where the
method tries to learn an efficient representation for each chemical, effect and protein in the dataset. After a specific
given number of training iterations, the method stores the current values of the tensor objects’ embeddings. In the
prediction phase, the method is able to provide a score for a given (chemical, effect, protein) combination using the
learnt embeddings vectors. This is achieved by processing the embeddings corresponding to the combination’s objects
through the same scoring function used in the training phase. This procedure is shown in prediction part in (Figure 1).
Multiple vector embeddings. The ComplEx model (24) has introduced the use of multiple vectors to represent single
tensor objects. This allowed it to encoding both ordered and unordered tensor combinations. In our work, we use the
TriModel embeddings (26) which is a similar approach that utilizes three embedding vectors for each tensor object. This
enables efficiently encoding ordered combination like the ComplEx model with higher accuracy due to the extended
representation.
Modelling embedding interactions. The embedding interaction function, the scoring function, of the TriModel uses
a combination of symmetric and asymmetric products to encode embedding interactions. This allow the method to





























νc are the three vector representations of the object c and k is the size of the single embedding vectors.



















and third products, then, are asymmetric while the second product is a symmetric procedure.
Training objective. The training objective of the TriVec model is to maximise the score of the true combinations and
to minimise the scores of the other combinations as indicated in (Eq. 1). This is achieved through a multi-class loss
objective that tries to maximise the score of each true combination compared to all possible corruption of its sides.
For example, a true combination like (27-hydroxycholesterol, increases the expression of, CCN5) is compared to all
combinations in the format of (· · · , increases the expression of, CCN5) and (27-hydroxycholesterol, increases the
expression of, · · · ) where the dots represents all the possible values of its category. This procedure is executed using the
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νk |) is a regularisation term that represents the nuclear 3-norm (27) that
is used for model generalisation purposes. This loss allows tensor factorisation methods to provide high accuracy
predictions (27), however, it has limited scalability (26). This occurs since the function processes the full vocabulary of
tensor objects for each training instance. Therefore, it has a a quadratic space and time complexity unlike the traditional
ranking objectives that have linear time and space complexity (23, 24, 28).
We also assess the performance of the TriVec method using a pointwise logistic loss function which enables highly
scalable predictions compared to the previous multi-class loss approach. It is, however, known to have inferior accuracy




log(1 + exp[−l(c,e,p) · ηM(c,e,p)]), (4)
where l(c,e,p) denotes the true label of the combination (c, e, p) which is equal to 1 if the combination is true and 0
otherwise.
Results
In this section, we discuss the design and configuration of our experiments. We first present the setup of our model
training strategy: the models training configurations and the details parameters grid search. We then discuss our
evaluation protocol, evaluation metrics and benchmarking data configuration. Finally, we compare the outcome
evaluation results of the TriVec model to other approaches in terms of both the accuracy and efficiency.
Experimental setup. In our experiments, we use the CTD38E benchmarking dataset which we have generated. The
dataset is divided into two splits: training and testing. We divide the training split into two random splits for training
and validation (90% for training and 10% for validation). The testing split is only used of the evaluation of investigated
models.
Model MRR Hits@10
AUC-ROC AUC-PR Iter. time Tot. time
N01 N10 N50 N01 N10 N50 (Sec.) (Min.)
TransE 0.07 0.20 0.99 0.99 0.99 0.99 0.93 0.82 1 19
DistMult 0.10 0.20 0.97 0.91 0.96 0.97 0.91 0.83 1 18
ComplEx 0.09 0.19 0.98 0.93 0.97 0.98 0.93 0.85 2 37
TriVec - Pt 0.09 0.20 0.98 0.98 0.98 0.99 0.94 0.86 19 33
TriVec - MC 0.28 0.41 0.99 0.99 0.99 0.99 0.95 0.88 32 151
Table 1: A Comparison between the TriVec model and other models model in terms of the mean reciprocal rank,
Hits@10, area under the ROC and precision-recall curves, the training runtime for each training iteration and the total
training runtime.
We compare the TriVec model to other tensor factorisation methods such as the DistMult and ComplEx models. We
also compare it to the TransE model (28) which is a distance-based graph embedding model which can be utilised to
perform tensor completion. We train all models through a grid search procedure to find the best hyperparameters for
each model. The search space of the hyperparameters is defined as follows: the learning rate lr ∈ {0.1, 0.3, 0.5},
embeddings size k ∈ {50, 75, 100, 150, 210} and batch size b ∈ {1000, 3000, 5000, 8000}. The rest of the grid search
hyper parameters are defined as follows: in the ranking loss approach, we use the negative sampling ratio n ∈ {2, 5, 10},
and in the multi-class approach we use the regularisation weight λ ∈ {0.1, 0.3, 0.35, 0.01, 0.03, 0.035} and dropout
d ∈ {0.0, 0.1, 0.2, 0.01, 0.02}. In the ranking loss approach, the number of training epochs is fixed to 1000. On the
other hand, the number of epochs in the multi-class loss is 250.
Evaluation protocol. We use the testing split of the CTD38E dataset to assess the predictive accuracy and required
training runtime of each of the investigated methods. To assess the predictive accuracy, we use different types of metrics
such as mean reciprocal rank and Hits@10, area under the ROC and precision recall curves. In the following, we give a
short description of each of these metrics.
• Mean reciprocal rank (MRR). A ranking metric that is specified in assessing the quality of the highest predicted
item in a rank. In our study, we use the MRR metric to assess if the model is able to find the right chemical
and protein of a combination (in the testing split) in the set of all possible chemicals and drugs. This procedure
resembles the link prediction procedure for knowledge graph completion (28).
• Hits@10. A ranking metric that has the same corruption mechanism and negative to positive ratio as the MRR
metric. However, the Hits@10 focuses on the top 10 ranked items where it is equal to one if the item is found in
the top 10 rank and zero otherwise. In our experiments, the reported Hits@10 values are the average of all the
Hits@10 values of each testing combination.
• The area under the ROC and precision recall curves (AUC-ROC and AUC-PR). We use both these metrics with
different positive to negative ratios to evaluate the models’ sensitivity and specificity. We use three ratio, 1:1, 1:10
and 1:50 respectively, where the negative samples are generated randomly for each of the investigated chemical
effects. The randomly generated negatives are filtered such that they do not intersect with any of the known
combinations of the investigated effect. The AUC-ROC and AUC-PR metrics are then computed per chemical
effect and averaged on the overall number of effects available in the data testing split.
Implementation details. We use TensorFlow framework (GPU) on Python 3.5 to perform our experiments. All
experiments were executed on a Linux machine with processor Intel(R) Core(TM) i70.4790K CPU @ 4.00GHz, 32 GB
RAM, and an nVidia Titan Xp GPU. We have published the dataset and training logs; a set of model predictions are
published in a figshare repository at: https://figshare.com/articles/CTD-experiment/9383918.
The source of our experiments is also published at: https://github.com/samehkamaleldin/ecpi.
Comparison with other approaches. (Table 1) presents a comparison between the TriVec method and other approaches
in terms of both predictive accuracy metrics and training runtime. The results show that the TriVec model achieves
significantly better scores compared to other approaches in terms of the 1-versus-all negative to positive metrics (MRR
and Hits@10). The results show that the TriVec model with the multi-class loss approach achieves the best results
in terms of all the predictive accuracy metrics. For example, the results show that the TriVec -MC approach achieve
0.28 MRR score which is approximately 200% better than the scores of its pointwise loss version, ComplEx, DistMult,
TransE models. The Hits@10 score of the TriVec -MC method is also approximately 100% better than all the other
approaches.
The multi-class version of the TriVec model also achieves the best results in terms of the area under the ROC and
precision recall curves. However, the difference between its scores and the scores of other models is small (ranges from
1% to 2%) in all the negative sampling configurations. The results also show that the achieved enhancements of the
TriVec model positively correlate with the negative to positive ratio. This shows that the TriVec model is able to provide
better results than other approaches in harder evaluation settings (N50), which can be supported by its results on the
1-versus-all evaluation metrics (MRR and Hits10).
Despite the predictive accuracy enhancements achieved by the multi-class loss version of the TriVec model, it requires
significantly higher training time compared to all other approaches as shown in (Table 1). In this context, the results
show that the TransE and DistMult model require the least training time compared to all other methods.
Discussion
In this section, we discuss in details the findings of our experiments and the details of evaluation scores of the highest
performing methods in terms of the AUC-PR for each of the investigated chemical effects. We also discuss the different
properties and features that the family of tensor factorisation methods enable. We then discuss the challenges and
limitations associated with using tensor factorisation techniques for predicting the effects of chemicals on the human
proteins. Finally, we discuss the intended future activities that we intend to perform in upcoming works to extend the
scope and objective of this study.
Scalability. Tensor factorisation methods are representation learning techniques that operate by learning efficient
vector representations of tensor objects. They then use representations to assess the factuality of tensor combinations.
The embedding learning procedure is known to operate with linear time and space complexity (24, 26). This allows
tensor factorisation methods to provide scalable predictions compared to other traditional approaches that require more
complex feature processing routines.
Furthermore, the predictive procedure of the tensor factorisation methods is a constant time complexity routine (O1).
This gives them a significant scalability advantage over other approaches that require feature processing in their
predictive procedure after training.
Significance to clinical research. Despite the high accuracy of computational approaches in multiple biological
inference tasks, they are never supposed to replace clinical experimentation. They however, aim to assist researchers in
biological studies in prioritizing their experimentation configurations. For example, our study aims to assist biologists
who are experimenting on different chemical substances to assess their effects on human proteins. Our proposed
computational approach provides predictions that enables ranking possible configurations (combinations) of chemicals,
proteins and their associated chemical effects according to their likelihood of being present. Biologists can use this rank
to prioritize the order of executed experimentation to focus on the highest ranked combinations.
Limitations. Despite the high predictive accuracy of the tensor factorisation approaches, they are not easily interpreted.
These methods operate as black boxes where it is hard to determine which set of features have affected their predictions.
This also affects the trust in their predictions, especially in the biomedical domain, as it is critical to understand the
rationale behind predictions to avoid misinformed judgements.
Tensor factorisation procedures build representations of tensor objects using their existing known combinations.
Therefore, they provide low quality representations of the under represented objects (22). In the context of biological
information, the coverage of biological entities has a high variance due to the unbalanced focus of clinical and research
studies of biological entities such as proteins, drugs, etc. Therefore, this affects the quality of representations of tensor
factorisation methods of the under represented objects. In addition, the tensor factorisation methods are unable to
provide beneficial representation of newly introduced objects e.g. new chemicals and proteins, as they require prior
information to operate.
Future works. In future works, we intend to incorporate the information about the associated body tissues of each
chemical–protein interactions. This will enable more accurate and specialised effects since the interactions between
chemicals and proteins are strongly affected by the associated tissue context.
We also aim to experiment with representation learning methods that utilize protein and chemical structures rather than
their prior information. This direction will enable more accurate and efficient predictions for new and under studied
chemicals and proteins.
Conclusions
In this work, we have studied the problem of identifying the effects of the interactions between chemicals and human
proteins. We have shown the importance of computational methods in assisting clinical research in this particular task.
We have then proposed using tensor factorisation methods to predict the effects of chemicals on human proteins where
we modelled the chemicals, their effects and the proteins as a tensor. We then used tensor factorisation to learn efficient
representations of the tensor objects to be able to predict new combinations.
We have adopted the TriVec method as our main approach, and we have built a benchmarking dataset (CTD38E) based
on the comparative Toxicogenomics database to train and evaluate our investigated approaches. We have then shown by
computational experimental evaluation that the TriVec method outperforms other known tensor factorisation methods in
the studied task in terms of different evaluation metrics such as the MRR, Hits@10 and the area under the ROC and
precision recall curves.
Finally, we have discussed different properties and limitations of the different tensor factorisation approaches, and we
have presented the set of intended future activities to extend the scope and objective of this study.
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